Literature DB >> 4427220

Importance of the use of the appropriate pharmacokinetic model to analyze in vivo enzyme constants.

A J Sedman, J G Wagner.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4427220     DOI: 10.1007/BF01061506

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


× No keyword cloud information.
  7 in total

1.  HUMAN LIVER--ALCOHOL DEHYDROGENASE. KINETIC AND PHYSICOCHEMICAL PROPERTIES.

Authors:  J P VONWARTBURG; J L BETHUNE; B L VALLEE
Journal:  Biochemistry       Date:  1964-11       Impact factor: 3.162

2.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

3.  Variations in absorption and elimination rates of ethyl alcohol in a single subject.

Authors:  J G Wagner; J A Patel
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-07

4.  Blood flow limitations in interpreting Michaelis constants for ethanol oxidation in vivo.

Authors:  R L Dedrick; D D Forrester
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

5.  Explanation of dose-dependent decline of diphenylhydantoin plasma levels by fitting to the integrated form of the Michaelis-Menten equation.

Authors:  N Gerber; J G Wagner
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1972-05

6.  Thiopental pharmacokinetics.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

7.  Some catalytic properties of human liver alcohol dehydrogenase.

Authors:  A H Blair; B L Vallee
Journal:  Biochemistry       Date:  1966-06       Impact factor: 3.162

  7 in total
  7 in total

1.  Nonlinearity detection: advantages of nonlinear mixed-effects modeling.

Authors:  E N Jonsson; J R Wade; M O Karlsson
Journal:  AAPS PharmSci       Date:  2000

2.  A tracer interaction method for nonlinear pharmacokinetics analysis: application to evaluation of nonlinear elimination.

Authors:  P Veng-Pedersen; J A Widness; J Wang; R L Schmidt
Journal:  J Pharmacokinet Biopharm       Date:  1997-10

3.  On the identification of Michaelis-Menten elimination parameters from a single dose-response curve.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

4.  The deterministic identifiability of nonlinear pharmacokinetic models.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

5.  Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation: II. Michaelis-Menten kinetics.

Authors:  I Gonda
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

6.  Dose-dependent pharmacokinetics of benzoic acid following oral administration of sodium benzoate to humans.

Authors:  K Kubota; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Computer modeling of the pharmacokinetics of Fluorouracil and thymine and their kinetic interaction in normal dogs.

Authors:  J M Covey; J A Straw
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.